Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Diagnostics
 More »

  • Quest Acquires Concentra's Toxicology, Clinical Lab Business
    Quest Diagnostics today said it has acquired the toxicology and clinical laboratory ... Quest Diagnostics today said it has acquired the toxicology and clinical laboratory ...
    5-16-2013
  • FDA Approves Roche EGFR Mutation CDx for NSCLC
    Ph.D., director of the Office of In Vitro Diagnostics and Radiological Health, in a statement. "Companion diagnostics play an important role in determining which ...
    5-15-2013
  • Highlights from AACR
    ... An agreement between Advanced Cell Diagnostics (ACD) and The Johns Hopkins University's Sidney Kimmel Comprehensive Cancer Center centers on the use of the company's RNAscope® ...
    5-15-2013
  • VC Investment: Not Quite Dead?
    Another recent winner of Q1 financing was BiOptix Diagnostics, a Boulder, CO, company developing its E-SPR (enhanced surface plasmon resonance) technology platform for the ...
    5-15-2013
  • Making Vaccines from Parts
    Novartis Vaccines and Diagnostics' Philip Dormitzer, Ph.D., and his colleagues today report in Science Translational Medicine that they have successfully started and completed a ...
    5-14-2013
  • Two Animal Diagnostics Firms Take on France
    Swiss animal diagnostics firm Prionics is teaming up with Belgian veterinary diagnostics company Bio-X Diagnostics to make Prionics' diagnostic solutions available to global ...
    5-13-2013
  • Companion Diagnostics: 52 Pick-Up
    Following are three lists depicting recent activity in the development of companion diagnostics: a rundown of all 15 FDA-approved companion diagnostics, as listed on the "Companion ...
    5-9-2013
  • Cancer Diagnostics, Pushing the Boundaries
    with the potential for use in diagnostics, drug discovery and development, and ... Securities observed that molecular diagnostics are "clearly an essential part of ...
    5-8-2013
  • Analytik Jena Acquires Sepsis Test Among SIRS-Lab Assets
    Analytik Jena will expand into the market for sepsis diagnostics by acquiring all assets ... to focus more strongly on routine diagnostics, working more closely with hospital and ...
    5-6-2013
  • New International Collaboration Aims to Develop Drugs, Diagnostics...
    molecules, biological materials, diagnostics, and other devices resulting from ... announced. New International Collaboration Aims to Develop Drugs, Diagnostics, More
    5-2-2013
  • Algeta Expands Cancer Drug Collaboration with Lumiphore
    Algeta also has the right to develop in vivo companion diagnostics for radio-imaging. Financial terms were not disclosed. The companies originally signed an option/license ...
    5-2-2013
  • Exposing the Exposome
    ... "A few years from now, these approaches will become routine, and these tools will undoubtedly also be embraced by diagnostics and pharmaceutics markets," says Dr. Van Eden. ...
    5-1-2013
  • Biomarkers Take Center Stage
    ... And since the intellectual property rights are unencumbered, Affimers in those arrays can be licensed to the end users to develop diagnostics that can be validated as time goes on. ...
    5-1-2013
  • Metabolomics Advances Reshape Dx Arena
    will inevitably lead to development of rapid and comprehensive disease diagnostics. ... signatures will make rapid bedside diagnostics possible," agreed Chris Beecher, Ph.D., ...
    5-1-2013
  • Separation of Therapeutic Biomolecules
    ... The problem presented by Reinhard Braaz at Roche Diagnostics is the high back pressure during production in a 60 cm diameter packed bed column containing butyl-4-FF, a semi-rigid ...
    5-1-2013
  • More »

    Journal Articles

  • Treatment Options to Manage Wound Biofilm
    Curtis E. Jones, John P. Kennedy
    Advances in Wound Care
    Conclusion: Bioburden is a significant barrier to healing for all chronic wounds. Molecular diagnostics provide the first objective means of assessing wound bioburden. The accuracy ...
  • Prevalence and Heritability of Clusters for Diagnostic Components...
    Juan C. Lopez-Alvarenga, Carolina Solís-Herrera, Jack W. Kent, Deepali Jaju, Sulayma Albarwani, Saheed Al Yahayee, M. Osman Hassan, Riad Bayoumi, Anthony G. Comuzzie
    Metabolic Syndrome and Related Disorders
    The WHO criteria yielded the highest heritability for a MetS diagnosis (h2 = 0.9), followed by NCEP (0.48) and IDF (0.38). The rationale of the MetS diagnostics is based on insulin ...
  • Neurology Diagnostics Security and Terminal Adaptation for PocketNeuro...
    C. Chemak, M.-S. Bouhlel, J.-C. Lapayre
    Telemedicine and e-Health
    Neurology Diagnostics Security and Terminal Adaptation for PocketNeuro Project Telemedicine and e-Health The PocketNeuro project supports transfer of image and text to a mobile ...
  • Outcomes from a Comprehensive Stroke Telemedicine Program
    Mona N. Bahouth, Yan Xiao, Peter Hu, Claudia R. Baquet, Colin F. Mackenzie, Marian P. LaMonte
    Telemedicine and e-Health
    This case control prospective study for acute stroke management compared telemedicine, telephone, and face-to-face evaluations. Telemedicine diagnostics and examination were as ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll